Cardinal Health Inc
12 nominees · 3 ballot items.
Election of 12 directors; advisory vote to approve the compensation of our named executive officers; ratification of the appointment of Ernst & Young LLP as our independent auditor.
Follow how the vote landed and what changed on Cardinal Health Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Directors
ManagementBoard: FORVote for the 12 director nominees to serve until the next annual meeting of shareholders.
- 2
Advisory Vote to Approve the Compensation of Our Named Executive Officers
ManagementBoard: FORVote, on a non-binding advisory basis, to approve the compensation of Cardinal Health's named executive officers as disclosed in the proxy statement.
- 3
Ratification of the Appointment of Ernst & Young LLP as Independent Auditor
ManagementBoard: FORRatify Ernst & Young LLP as Cardinal Health's independent auditor for the fiscal year ending June 30, 2026.
Nominees on the ballot12
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 6.5% | 15,288,709 | $3.2B |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.9% | 13,732,309 | $2.9B |
| 3 | STATE STREET CORP | 5.2% | 12,074,518 | $2.6B |
| 4 | BlackRock, Inc. | 4.3% | 10,022,880 | $2.1B |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 2.5% | 5,827,151 | $1.2B |
| 6 | BlackRock, Inc. | 2.4% | 5,619,711 | $1.2B |
| 7 | WCM INVESTMENT MANAGEMENT, LLC | 1.7% | 4,006,636 | $827M |
| 8 | WELLINGTON MANAGEMENT GROUP LLP | 1.7% | 3,945,851 | $834M |
| 9 | BlackRock, Inc. | 1.2% | 2,698,694 | $570M |
| 10 | FMR LLC | 1.1% | 2,507,397 | $530M |
Other Healthcare sector meetings6
Upcoming shareholder meetings at Cardinal Health Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Cardinal Health Inc 2025 annual meeting?
- Cardinal Health Inc (CAH) holds its 2025 annual shareholder meeting on Wednesday, November 5, 2025.
- What is the record date for the Cardinal Health Inc 2025 meeting?
- The record date for the Cardinal Health Inc 2025 meeting is Monday, September 8, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Cardinal Health Inc's 2025 meeting?
- The board is presenting 12 director nominees at the Cardinal Health Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Cardinal Health Inc 2025 meeting?
- Shareholders will vote on 3 proposals at the Cardinal Health Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.